KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Illumina (ILMN) Cash & Equivalents: 2009-2025

Historic Revenue - Interest and Investment Income for Illumina (ILMN) over the last 1 years, with Apr 2010 value amounting to $1.5 billion.

  • Illumina's Cash & Equivalents rose 20.83% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 20.83%. This contributed to the annual value of $1.1 billion for FY2024, which is 7.54% up from last year.
  • Latest data reveals that Illumina reported Cash & Equivalents of $1.1 billion as of Q3 2025, which was up 12.42% from $934.0 million recorded in Q2 2025.
  • In the past 5 years, Illumina's Cash & Equivalents ranged from a high of $4.4 billion in Q2 2021 and a low of $869.0 million during Q3 2024.
  • Over the past 3 years, Illumina's median Cash & Equivalents value was $1.1 billion (recorded in 2024), while the average stood at $1.2 billion.
  • Data for Illumina's Revenue - Interest and Investment Income shows a peak YoY grew of 9.66% (in 2010) over the last 5 years.
  • Over the past 2 years, Illumina's Revenue - Interest and Investment Income (Quarterly) stood at $1.5 billion in 2009, then grew by 9.66% to $1.5 billion in 2010.
  • Its Cash & Equivalents was $1.1 billion in Q3 2025, compared to $934.0 million in Q2 2025 and $1.1 billion in Q1 2025.